Patent US4112041A successfully refreshed from Google Patents.
US4433111A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fluorine-containing hydrogel-forming polymeric materials
Assignee: Kelvin Lenses Ltd
•
Filing: 1981-10-08
•
Granted: 1984-02-21
•
Expires: 2001-10-08
Abstract
Abstract Polymeric materials suitable for biomedical applications, particularly in making contact lenses, are formed by copolymerization and crosslinking of: (1) an amide of an unsaturated carboxylic acid such as acrylamide or methacrylamide; (2) an N-vinyl lactam such as N-vinyl pyrrolidone; (3) an ester of an unsaturated carboxylic acid such as a hydroxy-substituted ester of acrylic or methacrylic acid; (4) an unsaturated carboxylic acid such as acrylic or methacrylic acid; and (5) a hydrophobic monomer component comprising: (a) a fluorine-containing polymerizable monomer having a fluoroaliphatic side chain, such as fluoroalkyl acrylate or methacrylate, and (b) a non-fluorine-containing polymerizable hydrophobic vinyl monomer such as styrene; crosslinking with a crosslinking agent either being carried out during copolymerization or subsequently. The resulting polymeric materials may be machined to produce a contact lens form and then hydrated to form a hydrogel which is suitable for use as an extended wear contact lens.
Inventors
- 👤 Brian J. Tighe
- 👤 Howard J. Gee
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 08:15
CPC Classifications
G; G02; G02B; G02B1/00; G02B1/04; G02B1/041; G02B1/043; C; C08; C08F; C08F220/00; C08F220/02; C08F220/52; C08F220/54; C08F226/00; C08F226/06; C08F8/00; C08F8/18; C08F8/20
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
290 words
A crosslinked, fluorine-containing polymeric material suitable for use in biomedical applications, containing units derived either by simultaneous copolymerisation and crosslinking or by copolymerisation and subsequent cross-linking of the following monomers: (1) 20 to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types (a) and (b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, unsaturated carboxylic acid or ester or a non-fluorine-containing unsaturated alcohol which, after copolymerisation of monomers (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof, and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from the group consisting of vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, the crosslinking having been effected with crosslinking amounts of a crosslinking agent, which, in the case of simultaneous copolymerisation and crosslinking, is an ester of a diol and acrylic or methacrylic acid or is divinylbenzene, or, in the case of crosslinking subsequent to copolymerisation, is a latent crosslinking agent which is a diamide of an unsaturated aliphatic carboxylic acid, an anhydride of an aliphatic or aromatic carboxylic acid, a diepoxide or dicumyl peroxide, the crosslinking agent having been used in an amount of up to 5 weight % based on the total weight of monomers (1) to (5).
Claim 2
Dependent Claim
290 words
A crosslinked, fluorine-containing polymeric material suitable for use in biomedical applications, containing units derived either by simultaneous copolymerisation and crosslinking or by copolymerisation and subsequent cross-linking of the following monomers: (1) 20 to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types (a) and (b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, unsaturated carboxylic acid or ester or a non-fluorine-containing unsaturated alcohol which, after copolymerisation of monomers (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof, and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from the group consisting of vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, the crosslinking having been effected with crosslinking amounts of a crosslinking agent, which, in the case of simultaneous copolymerisation and crosslinking, is an ester of a diol and acrylic or methacrylic acid or is divinylbenzene, or, in the case of crosslinking subsequent to copolymerisation, is a latent crosslinking agent which is a diamide of an unsaturated aliphatic carboxylic acid, an anhydride of an aliphatic or aromatic carboxylic acid, a diepoxide or dicumyl peroxide, the crosslinking agent having been used in an amount of up to 5 weight % based on the total weight of monomers (1) to (5).
Claim 3
Dependent Claim
14 words
A polymeric material according to claim 1 wherein component (5a) contains a fluoroalkyl group.
Claim 4
Dependent Claim
17 words
A polymeric material according to claim 2 wherein the fluoroalkyl group contains 1 to 12 carbon atoms.
Claim 5
Dependent Claim
15 words
A polymeric material according to claim 1 wherein component (5a) contains a terminal trifluoromethyl group.
Claim 6
Dependent Claim
34 words
A polymeric material according to claim 1 wherein component (5a) contains a fluoro-substituted aliphatic ester group of the general formula ##STR4## where X represents a fluoro-substituted alkyl group containing up to 6 carbon atoms.
Claim 7
Dependent Claim
63 words
A polymeric material according to claim 1 wherein component (5a) is a fluorine-containing unsaturated ester selected from the group consisting of trifluoroethyl acrylate, trifluoroethyl methacrylate, hexafluoroisopropyl acrylate, hexafluoroisopropyl methacrylate, 1,1,3-trihydroperfluoropropyl methacrylate, a perfluoroalkyl alkyl methacrylate of the formula ##STR5## and a fluoro-alcohol methacrylate of the formula ##STR6## wherein m and n are integers such that the compounds contain up to 12 carbon atoms.
Claim 8
Dependent Claim
19 words
A polymeric material according to claim 1 containing units derived from 1 to 9 mole % of component (5a).
Claim 9
Dependent Claim
25 words
A polymeric material according to claim 1 wherein component (1) is acrylamide, methacrylamide or diacetone acrylamide or a mixture of two or all of these.
Claim 10
Dependent Claim
12 words
A polymeric material according to claim 1 wherein component (2) is N-vinylpyrrolid-2-one.
Claim 11
Dependent Claim
16 words
A polymeric material according to claim 1 wherein component (3) is hydroxy-propyl acrylate or hydroxy-ethyl methacrylate.
Claim 12
Dependent Claim
23 words
A polymeric material according to claim 1 wherein component (5b) is styrene, an ester of acrylic or methacrylic acid or a mixture thereof.
Claim 13
Dependent Claim
30 words
A polymeric material according to claim 1 wherein the crosslinking agent in the case of simultaneous copolymerisation and crosslinking is ethylene glycol dimethacrylate, a polyethylene oxide dimethacrylate or divinyl benzene.
Claim 14
Dependent Claim
18 words
A shaped article, suitable for producing a contact lens comprising a polymeric material as claimed in claim 1.
Claim 15
Dependent Claim
245 words
A process for preparing a crosslinked fluorine-containing polymeric material suitable for use in biomedical applications which comprises: (a) simultaneous copolymerisation and crosslinking in a mould of a monomer mixture comprising: (1) 20 to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types (a) and (b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, unsaturated carboxylic acid or ester or a non-fluorine containing unsaturated alcohol which, after copolymerisation of monomers (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from the group consisting of vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, the crosslinking having been effected with a crosslinking amount of a cross-linking agent which is an ester of a diol and acrylic or methacrylic acid or is divinylbenzene, the crosslinking agent being used in an amount of up to 5 weight % based on the total weight of monomers (1) to (5).
Claim 16
Dependent Claim
245 words
A process for preparing a crosslinked fluorine-containing polymeric material suitable for use in biomedical applications which comprises: (a) simultaneous copolymerisation and crosslinking in a mould of a monomer mixture comprising: (1) 20 to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types (a) and (b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, unsaturated carboxylic acid or ester or a non-fluorine containing unsaturated alcohol which, after copolymerisation of monomers (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from the group consisting of vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, the crosslinking having been effected with a crosslinking amount of a cross-linking agent which is an ester of a diol and acrylic or methacrylic acid or is divinylbenzene, the crosslinking agent being used in an amount of up to 5 weight % based on the total weight of monomers (1) to (5).
Claim 17
Dependent Claim
253 words
A process for preparing a crosslinked, flourine-containing polymeric material suitable for use in biomedical applications, which comprises: (i) copolymerising a monomer mixture comprising: (1) 20 to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types (a) and (b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, unsaturated carboxylic acid or ester or a non-fluorine-containing unsaturated alcohol which, after copolymerisation of monomers (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof, and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from the group consisting of vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, and (ii) compression or injection moulding the resulting copolymer in the presence of crosslinking amount of a latent crosslinking agent which is a diamide of an unsaturated aliphatic carboxylic acid, an anhydride of an aliphatic or aromatic carboxylic acid, a diepoxide or dicumyl peroxide, the crosslinking agent having been used in an amount up to 5 weight % based on the total weight of monomers (1) to (5).
Claim 18
Dependent Claim
253 words
A process for preparing a crosslinked, flourine-containing polymeric material suitable for use in biomedical applications, which comprises: (i) copolymerising a monomer mixture comprising: (1) 20 to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types (a) and (b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, unsaturated carboxylic acid or ester or a non-fluorine-containing unsaturated alcohol which, after copolymerisation of monomers (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof, and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from the group consisting of vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, and (ii) compression or injection moulding the resulting copolymer in the presence of crosslinking amount of a latent crosslinking agent which is a diamide of an unsaturated aliphatic carboxylic acid, an anhydride of an aliphatic or aromatic carboxylic acid, a diepoxide or dicumyl peroxide, the crosslinking agent having been used in an amount up to 5 weight % based on the total weight of monomers (1) to (5).
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-02-20 | 1987-08-22 | 1988-02-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-02-20 | 1991-08-22 | 1992-02-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-02-20 | 1995-08-22 | 1996-02-21 | $7700.00 | Window Closed / Lapsed |